Countries rely on out-of-pocket (OOP) spending to different degrees and employ varying techniques. The article examines trends in OOP spending in ten high-income countries since 2000, and analyzes their relationship to self-assessed barriers to accessing health care services. The countries are Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, the United Kingdom, and the United States. Data from three sources are employed: OECD statistics, the Commonwealth Fund survey of individuals in each of ten countries, and country-specific documents on health care policies. Based on trends in OOP spending, we divide the ten countries into three groups and analyze both trends and access barriers accordingly. As part of this effort, we propose a conceptual model for understanding the key components of OOP spending. There is a great deal of variation in aggregate OOP spending per capita spending but there has been convergence over time, with the lowest-spending countries continuing to show growth and the highest spending countries showing stability. Both the level of aggregate OOP spending and changes in spending affect perceived access barriers, although there is not a perfect correspondence between the two. There is a need for better understanding the root causes of OOP spending. This will require data collection that is broken down into OOP resulting from cost sharing and OOP resulting from direct payments (due to underinsurance and lacking benefits). Moreover, data should be disaggregated by consumer groups (e.g. income-level or health status). Only then can we better link the data to specific policies and suggest effective solutions to policy makers.
A historically fragmented U.S. health care system, where care has been delivered by multiple providers with little or no coordination, has led to increasing issues with access, cost, and quality. The Affordable Care Act included provisions to use Medicare, the U.S. near universal public coverage program for older adults, to broadly implement Accountable Care Organization (ACO) models with a triple aim of improving the experience of care, the health of populations, and reducing per capita costs. Private payers in the U.S. are also embracing ACO models. Various European countries are experimenting with similar reforms, particularly those in which coordinated (or integrated) care from a network of providers is reimbursed with bundled payments and/or shared savings. The challenges for these reforms remain formidable and include: (1) overcoming incentives for ACOs to engage in rationing and denial of care and taking on too much financial risk, (2) collecting meaningful data that capture quality and enable rewarding quality improvement and not just volume reduction, (3) creating incentives for ACOs that do not accept much risk to engage in prevention and health promotion, and (4) creating effective governance and IT structures that are patient-centered and integrate care.
This article maps current approaches to public reporting on waiting times, patient experience and aggregate measures of quality and safety in 11 high-income countries (Australia, Canada, England, France, Germany, Netherlands, New Zealand, Norway, Sweden, Switzerland and the United States). Using a questionnaire-based survey of key national informants, we found that the data most commonly made available to the public are on waiting times for hospital treatment, being reported for major hospitals in seven countries. Information on patient experience at hospital level is also made available in many countries, but it is not generally available in respect of primary care services. Only one of the 11 countries (England) publishes composite measures of overall quality and safety of care that allow the ranking of providers of hospital care. Similarly, the publication of information on outcomes of individual physicians remains rare. We conclude that public reporting of aggregate measures of quality and safety, as well as of outcomes of individual physicians, remain relatively uncommon. This is likely to be due to both unresolved methodological and ethical problems and concerns that public reporting may lead to unintended consequences.
1 September 2020 in Journal of Studies on Alcohol and Drugs
Electronic cigarettes (e-cigarettes) have gained popularity as a method to reduce conventional cigarette smoking, despite mixed evidence on their effectiveness. This study evaluates the relationship between overall and product-specific nicotine dependence and the transitions between dual use of cigarettes and e-cigarettes versus exclusive cigarette or e-cigarette use over time. This study used data from Waves 1–3 (2013–2016) of the Population Assessment of Tobacco and Health (PATH) Study. Weighted logistic regressions with person-level random effects tested relationships between nicotine dependence and dual versus exclusive use over time. Dual use transitions were then compared with the characteristics of e-cigarette devices used and reasons to use them. Higher tobacco dependence was associated with becoming or remaining a dual user rather than remaining or becoming an exclusive user of cigarettes or e-cigarettes (p < .05). Higher e-cigarette dependence was associated with remaining or becoming an exclusive e-cigarette user. The number of days smoking cigarettes or using e-cigarettes in the past 30 days was also associated with greater odds of remaining or transitioning to exclusive use of that product (p < .05). Exclusive e-cigarette users tended to invest more financially in their devices and were more likely to report owning modifiable devices. This study provides new evidence that established dual use and transitions to and from dual use are associated with higher tobacco dependence compared with remaining a cigarette- or e-cigarette-only user and that higher e-cigarette dependence is associated with becoming or remaining an exclusive user of e-cigarettes.